| 25/06/21 | NattoPharma ASA : - Delisting | AQ |
| 15/06/21 | NattoPharma : Received application for delisting | AQ |
| 14/06/21 | NattoPharma : Annual General Meeting in NattoPharma ASA | AQ |
| 10/06/21 | NattoPharma : OSLO BØRS - SUSPENDED | AQ |
| 09/06/21 | NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition | AQ |
| 1 day | +2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 54 | 08/02/2018 |
Robert Schrama
DFI | Director of Finance/CFO | - | 09/03/2020 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frode Marc Bohan
CHM | Chairman | 58 | 04/11/2004 |
| Director/Board Member | 52 | 01/02/2011 | |
Kjetil Ramsøy
BRD | Director/Board Member | 54 | 01/01/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +1.46% | - | - | 86.2M | |
| -0.52% | +2.66% | +58.86% | +163.79% | 1,062B | |
| +0.88% | +1.34% | +51.97% | +53.36% | 619B | |
| +0.89% | -4.42% | +25.34% | +66.55% | 431B | |
| +0.71% | +3.93% | +47.75% | +38.58% | 358B | |
| +0.64% | -0.63% | +36.39% | +41.44% | 293B | |
| +0.39% | -6.48% | +7.62% | +9.04% | 247B | |
| +1.51% | +6.01% | +44.36% | +68.92% | 219B | |
| +3.92% | -7.80% | +5.39% | -42.52% | 200B | |
| +1.80% | +1.47% | +20.79% | +69.31% | 162B | |
| Average | +1.34% | -1.90% | +33.16% | +52.05% | 399.14B | |
| Weighted average by Cap. | +0.65% | -0.83% | +41.60% | +78.43% |
Employees
18
Sector
Pharmaceuticals
